[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367049-105":59,"doc-detail-367049-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomarkers-suitable-for-early-detection-of-intrathoracic-cancers-in-primary-care-a-systematic-review","Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care - A Systematic Review","","Intrathoracic cancers, including lung cancer, mesothelioma, and thymoma, create diagnostic difficulties in primary care. Biomarkers are evaluated as potential tools to address these challenges, especially in low-prevalence settings. Searches in Embase and MEDLINE identified studies of suspected intrathoracic cancer with validated noninvasive biomarker measures. Fifty-two studies met inclusion criteria, assessing 108 biomarkers and panels. Several biomarkers showed strong diagnostic performance, yet few were tested in true low-prevalence conditions, requiring further validation before implementation in primary care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-suitable-for-early-detection-of-intrathoracic-cancers-in-primary-care-a-systematic-review/367049/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-suitable-for-early-detection-of-intrathoracic-cancers-in-primary-care-a-systematic-review/367049.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the systematic review address in primary care?","Question",{"text":112,"@type":113},"Intrathoracic cancers (lung cancer, mesothelioma, and thymoma) present diagnostic challenges in primary care, and low prevalence can reduce the effectiveness of usual diagnostic approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies selected for biomarker evaluation?",{"text":117,"@type":113},"The review used searches in Embase and MEDLINE and included studies that recruited participants with suspected intrathoracic cancer and reported at least one diagnostic measure for a validated noninvasive biomarker.",{"name":119,"@type":110,"acceptedAnswer":120},"What key limitation affects implementation of these biomarkers?",{"text":121,"@type":113},"Few biomarkers were evaluated in low-prevalence settings; further assessment is needed before using them for intrathoracic cancers in primary care.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367049,1790251403,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care: A Systematic Review  \nWasim Hamad1, Bogdan Grigore2, Hugo Walford3, Jaime Peters2, Panos Alexandris1,  \nStefanie Bonfield1, Laura Standen1, Rachel Boscott4, Dawnya Behiyat4, Isla Kuhn5, Richard D. Neal6, Fiona M. Walter1,4, and Natalia Calanzani7  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Intrathoracic cancers, including lung cancer, mesothelioma, and thymoma, present diagnostic challenges in primary care. Biomarkers could resolve some challenges. We synthesized evidence on biomarker performance for intrathoracic cancer detection in low-prevalence settings. A search in Embase and MEDLINE included studies that recruited participants with suspected intrathoracic cancer and reported on at least one diagnostic measure for a validated, noninvasive biomarker. Studies were excluded if participants were recruited based on a preestablished diagnosis. A total of 52 studies were included, reporting on 108 individual biomarkers and panels. Carcinoembryonic antigen, CYFRA 21-1, and VEGF were evaluated for lung cancer and mesothelioma. For lung cancer, carcinoembryonic antigen and CYFRA 21-1 were the most studied, with AUCs of\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.48 to –0.90 and 0.48 to –0.83, respectively. Pro–gastrin-releasing peptide (Pro-GRP) and neuron-specific enolase (NSE) had the highest negative predictive values (NPV) (98.2% and 96.9%, respectively), whereas Early Cancer Detection Test-Lung (Early CDT) and miRNA signature classifier panels showed NPVs of 99.3% and 99.0%, respectively, in smokers. For mesothelioma, fibrillin-3 and mesothelin plus osteopontin had AUCs of 0.93 and 0.91, respectively. Thymoma panels (binding AcHR + StrAb and binding AcHR + modulating AcHR + StrAb) had 100% NPVs inpatients with myasthenia gravis. The review highlights the performance of some biomarkers. However, few were evaluated in low-prevalence settings. Further evaluation is necessary before implementing these biomarkers for intrathoracic cancers in primary care. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nIntrathoracic cancers, including lung cancer, mesothelioma, and thymoma, present significant health challenges. Lung cancer was the leading cause of cancer-related deaths and the second most prevalent cancer globally in 2020 (1) . In the United Kingdom, there were 45,000 new cases and 35,000 deaths annually between 2016 and 2017 (2) . Mesothelioma caused 26,278 cancer-related deaths globally in 2020, and in the United Kingdom, it caused 2,500 deaths annually between 2017 and 2019, which is 10 times higher than those in the 1970s (3) . Thymoma, although being the most common tumor in the mediastinum among adults (4), has a  \n1Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Ki","cbCaisR6G5pT8KNj","https://ap.wps.com/l/cbCaisR6G5pT8KNj","pdf",2165923,16,"English","# Introduction\n# Methods and study selection\n# Diagnostic performance results\n## Lung cancer biomarkers\n## Mesothelioma biomarkers\n## Thymoma biomarkers\n# Conclusions and implications","[{\"question\":\"What problem does the systematic review address in primary care?\",\"answer\":\"Intrathoracic cancers (lung cancer, mesothelioma, and thymoma) present diagnostic challenges in primary care, and low prevalence can reduce the effectiveness of usual diagnostic approaches.\"},{\"question\":\"How were studies selected for biomarker evaluation?\",\"answer\":\"The review used searches in Embase and MEDLINE and included studies that recruited participants with suspected intrathoracic cancer and reported at least one diagnostic measure for a validated noninvasive biomarker.\"},{\"question\":\"What key limitation affects implementation of these biomarkers?\",\"answer\":\"Few biomarkers were evaluated in low-prevalence settings; further assessment is needed before using them for intrathoracic cancers in primary care.\"}]","Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care - A Systematic Review | PDF",1790169047,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e79584484192511e9b61479cfdb9ef2.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db3a080194a4c791cf63c2c7746f5c18.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c256b7843481dfb57f54845a8f2a7270.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/441c366ab31175e6fad06c1e1451dc21.webp",980,1311]